Live Roundups Editor's Desk Insights Executive Ops Weather About 🔍
Home › Business & Finance › Business Daily
Business & Finance

Business Daily

Business Daily
BBC Business Friday 25 September 2026, 09:41 UTC 1 min read
Key Points

Did trade frenemies find common ground at the White House?

Did trade frenemies find common ground at the White House?
Business Daily (ORG) the White House (LOCATION)
Originally published by BBC Business Read original →

Related Stories

China saw 'surprise' jump in U.S. orders ahead of Trump-Xi summit, private survey shows

American businesses ramped up orders for Chinese goods in the weeks leading up to the high-stakes summit this week, as companies positioned for continued stability between the world's two largest economies. The jump in orders was a "surprise," with shipments to the U.S. rising on both a yearly and monthly basis "as China's relative tariff position improved," according to China Beige Book, a New York-based research firm that surveyed 1,296 Chinese companies between Sept. 1-22. The gauge...

CNBC 25m ago

See which incumbents have the biggest cash advantage in the tightest U.S. House races

The most competitive races for control of the House of Representatives in the 2026 midterm election may be toss-ups on the political map. But in the most fiercely contested districts, one candidate often holds a massive financial edge. In 11 of the 19 incumbent-versus-challenger matchups rated as "toss ups" by The Cook Political Report with Amy Walter, a clear financial divide emerged:

CNBC 25m ago

Pimco Faces $35 Million Loss on Philadelphia Offices

Pacific Investment Management Co. is facing losses of around 70% on a commercial mortgage-backed security tied to a two-tower office complex in downtown Philadelphia.

Bloomberg Markets 25m ago

Pharma stock soars 150% on injectables deal with Wegovy maker Novo

Shares in Swedish microcap stock Nanexa more than doubled early Friday after the drug-delivery group revealed a $1.33 billion licensing deal with pharma giant Novo Nordisk. Nanexa, which trades on the Nasdaq First North Growth Market in Stockholm, said after the closing bell on Thursday it had penned a global licensing agreement covering Novo's long-acting injectable drugs for obesity, type 2 diabetes and other cardiometabolic issues. Its shares soared more than 150% at the open in Stockholm...

CNBC 27m ago